HOME>News & Media
Healthy bodies, healthy lives

 

Sunovion Pharmaceuticals Inc. is a fully integrated, research-based specialty pharmaceutical company dedicated to treating and preventing human disease by discovering, developing and commercializing innovative pharmaceutical products that are directed toward serving large and growing markets and unmet medical needs.
More >>

2012 | 2011 | 2010 | 2009 | 2008 DSPA 2009 Press Releases

 Date  Title
08/26/09 Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study
06/03/09 Study Demonstrating Lurasidone Is Effective In Patients With Schizophrenia Published in Journal of Clinical Psychiatry
05/20/09 Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data In Patients With Schizophrenia
05/11/09 Summary of Consolidated Financial Results for the Year Ended March 31, 2009
02/03/09 Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2009 (PDF 321kb)
Home | Who We Are | Our Products | For Our Patients | Working at Sunovion | For Healthcare Professionals | Site Map | Terms of Use | Privacy Policy | About DSP
Sunovion is a trademark of Dainippon Sumitomo Pharma Co., Ltd., Osaka, Japan. © 2012 Sunovion Pharmaceuticals Inc., Marlborough, MA 01752. All rights reserved.